Review article · 2019
Antibody Pretargeting Based on Bioorthogonal Click Chemistry for Cancer Imaging and Targeted Radionuclide Therapy
Bioconjugate Chemistry, 31(2), 159–173 · Published 19 December 2019 · DOI 10.1021/acs.bioconjchem.9b00761
In brief
“Antibody Pretargeting Based on Bioorthogonal Click Chemistry for Cancer Imaging and Targeted Radionuclide Therapy” is a 2019 review article by Aurélie Rondon and Françoise Degoul, published in Bioconjugate Chemistry. OpenAlex counts 103 citations as of 21 November 2026, which puts it in the top 1% of works published in 2019 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 103
- Most cited in
- 2023 (20)
- Field-weighted impact
- 1.48
- References
- 126
- Authors
- 2
Abstract
Bioorthogonal click chemistry—employing antibody-conjugated trans -cyclooctenes (TCO) and tetrazine (Tz)-based radioligands able to covalently bind in vivo —appeared recently as a potential alternative to circumvent the hematotoxicity induced by radioimmunotherapy of solid tumors. This Review focuses on the recent advances concerning TCO/Tz pretargeting in both cancer imaging and targeted-radionuclide therapy for prospective clinical transfer. We… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Rondon, A., & Degoul, F. (2019). Antibody Pretargeting Based on Bioorthogonal Click Chemistry for Cancer Imaging and Targeted Radionuclide Therapy. Bioconjugate Chemistry, 31(2), 159–173. https://doi.org/10.1021/acs.bioconjchem.9b00761
MLA 9
Rondon, Aurélie, and Françoise Degoul. “Antibody Pretargeting Based on Bioorthogonal Click Chemistry for Cancer Imaging and Targeted Radionuclide Therapy.” Bioconjugate Chemistry, vol. 31, no. 2, 2019, pp. 159–173. https://doi.org/10.1021/acs.bioconjchem.9b00761.
Chicago
Rondon, Aurélie and Françoise Degoul. 2019. “Antibody Pretargeting Based on Bioorthogonal Click Chemistry for Cancer Imaging and Targeted Radionuclide Therapy.” Bioconjugate Chemistry 31 (2): 159–173. https://doi.org/10.1021/acs.bioconjchem.9b00761.
Harvard
Rondon, A. and Degoul, F. (2019) ‘Antibody Pretargeting Based on Bioorthogonal Click Chemistry for Cancer Imaging and Targeted Radionuclide Therapy’, Bioconjugate Chemistry, 31(2), pp. 159–173. doi:10.1021/acs.bioconjchem.9b00761.
IEEE
A. Rondon and F. Degoul, “Antibody Pretargeting Based on Bioorthogonal Click Chemistry for Cancer Imaging and Targeted Radionuclide Therapy,” Bioconjugate Chemistry, vol. 31, no. 2, pp. 159–173, 2019, doi: 10.1021/acs.bioconjchem.9b00761.
BibTeX
@article{rondon2019antibody,
title = {{Antibody Pretargeting Based on Bioorthogonal Click Chemistry for Cancer Imaging and Targeted Radionuclide Therapy}},
author = {Rondon, Aurélie and Degoul, Françoise},
journal = {Bioconjugate Chemistry},
year = {2019},
volume = {31},
number = {2},
pages = {159--173},
doi = {10.1021/acs.bioconjchem.9b00761},
url = {https://doi.org/10.1021/acs.bioconjchem.9b00761}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2020 | 11 | |
| 2021 | 16 | |
| 2022 | 12 | |
| 2023 | 20 | |
| 2024 | 14 | |
| 2025 | 12 | |
| 2026 | 18 |
Its field-weighted citation impact is 1.48: it has been cited 1.48 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiopharmaceutical Chemistry and Applications
- bioorthogonal click chemistry
- trans-cyclooctene
- tetrazine
- targeted radionuclide therapy
- tumor imaging
- radioimmunotherapy
- monoclonal antibodies
- theranostics
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Rondon, A., & Degoul, F. (2019). Antibody Pretargeting Based on Bioorthogonal Click Chemistry for Cancer Imaging and Targeted Radionuclide Therapy. Bioconjugate Chemistry, 31(2), 159–173. https://doi.org/10.1021/acs.bioconjchem.9b00761
How many times has this paper been cited?
103 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Aurélie Rondon, Françoise Degoul.
What is the DOI of this paper?
10.1021/acs.bioconjchem.9b00761, permanently at https://doi.org/10.1021/acs.bioconjchem.9b00761. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.